Chromiun effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus

Endocrine Practice

Volumn 17, Issue 1, 2011, Pages 16-25

  Ali, Ather ^a   Ma, Yingying ^a   Reynolds, Jesse ^a   Wise Sr , John Pierce ^b   Inzucchi, Silvio E ^a   Katz, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM PICOLINATE; GLUCOSE; INSULIN; PLACEBO; CHROMIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; CHROMIUM; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 79952367370     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP10131.OR     Document Type: Article

References (33)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32 (Suppl 1):S62-S67.
2. Song Y, Manson JE, Tinker L, et al. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes. 2007;56:1898-1904. (Pubitemid 47025455)
3. Padwal R, Majumdar SR, Johnson JA, Varney J, McAlister FA. A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care. 2005;28:736-744. (Pubitemid 40315342)
4. Walker EA, Molitch M, Kramer MK, et al. Adherence to preventive medications: Predictors and outcomes in the Diabetes Prevention Program. Diabetes Care. 2006;29:1997-2002. (Pubitemid 44871177)
5. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. (Pubitemid 34437694)
6. Vallis M, Ruggiero L, Greene G, et al. Stages of change for healthy eating in diabetes: Relation to demographic, eating-related, health care utilization, and psychosocial factors. Diabetes Care. 2003;26:1468-1474. (Pubitemid 36929180)
7. Anderson RA, Polansky MM, Bryden NA, Canary JJ. Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. Am J Clin Nutr. 1991;54:909-916. (Pubitemid 21899015)
8. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann W. Chromium supplementation of human subjects: Effects on glucose, insulin, and lipid variables. Metabolism. 1983;32:894-899. (Pubitemid 13051139)
9. A scientific review: The role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2:14.
10. Federal Trade Commission. Companies advertising popular dietary supplement chromium picolinate can't substantiate weight loss and health benefit claims, says FTC. Released November 7, 1996. Available at: http://www.ftc.gov/ opa/1996/11/nut-21.shtm. Accessed June 25, 2010.
11. Office of Dietary Supplements, National Institutes of Health. Dietary Supplement Fact Sheet: Chromium. August 5, 2005. Available at: http://ods.od.nih.gov/factsheets/chromium.asp. Accessed June 25, 2010.
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
13. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63. (Pubitemid 30022895)
14. Faridi Z, Njike VY, Dutta S, Ali A, Katz DL. Acute dark chocolate and cocoa ingestion and endothelial function: A randomized controlled crossover trial. Am J Clin Nutr. 2008;88:58-63. (Pubitemid 351988683)
15. Corretti MC, Anderson TJ, Benjamin EJ, et al; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265. (Pubitemid 34084631)
16. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves A. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg. 1998;28:687-694. (Pubitemid 28481224)
17. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999;34:146-154.
18. Lee IK, Kim HS, Bae JH. Endothelial dysfunction: Its relationship with acute hyperglycaemia and hyperlipidemia. Int J Clin Pract Suppl. 2002;129:59-64.
19. Title LM, Cummings PM, Giddens K, Nassar BA. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: An effect prevented by vitamins C and E. J Am Coll Cardiol. 2000;36: 2185-2191.
20. Katz DL, Nawaz H, Boukhalil J, et al. Effects of oat and wheat cereals on endothelial responses. Prev Med. 2001;33:476-484. (Pubitemid 33035791)
21. Plotnick GD, Corretti MC, Vogel RA, Hesslink R Jr, Wise JA. Effect of supplemental phytonutrients on impairment of the flow-mediated brachial artery vasoactivity after a single high-fat meal. J Am Coll Cardiol. 2003;41:1744-1749. (Pubitemid 36584246)
22. Biarnés J, Fernández-Real JM, Fernández- Castañer M, del Mar García M, Soler J, Ricart W. Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin. Metabolism. 2005;54:235-239. (Pubitemid 40174853)
23. Ma Y, Njike VY, Millet J, et al. Effects of walnut consumption on endothelial function in type 2 diabetic subjects: A randomized controlled crossover trial. Diabetes Care. 2010;33:227-232.
24. Njike VY, Faridi Z, Shuval K, et al. Effects of sugar-sweetened and sugar-free cocoa on endothelial function in overweight adults. Int J Cardiol. 2009, In Press.
25. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care. 2009;32(Suppl 2):S314-S321.
26. Yazaki Y, Faridi Z, Ma Y, et al. A pilot study of chromium picolinate for weight loss. J Altern Complement Med. 2010;16:291-299.
27. Iqbal N, Cardillo S, Volger S, et al. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr Relat Disord. 2009;7:143-150.
28. Gunton JE, Cheung NW, Hitchman R, et al. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: A randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care. 2005;28:712-713. (Pubitemid 40315337)
29. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus - A review. Diabetes Technol Ther. 2006;8:677-687. (Pubitemid 44871498)
30. Martin J, Wang ZQ, Zhang XH, et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care. 2006;29:1826-1832. (Pubitemid 44156637)
31. Wang ZQ, Qin J, Martin J, et al. Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. Metabolism. 2007;56:1652-1655. (Pubitemid 350060933)
32. Faerch K, Borch-Johnsen K, Holst JJ, Vaag A. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: Does it matter for prevention and treatment of type 2 diabetes? Diabetologia. 2009;52:1714-1723.
33. Man CD, Toffolo G, Basu R, Rizza RA, Cobelli C. Use of labeled oral minimal model to measure hepatic insulin sensitivity. Am J Physiol Endocrinol Metab. 2008;295:E1152-E1159.